551 related articles for article (PubMed ID: 18622244)
1. Effects of hypertension therapy based on eprosartan on systolic arterial blood pressure and cognitive function: primary results of the Observational Study on Cognitive function And Systolic Blood Pressure Reduction open-label study.
Hanon O; Berrou JP; Negre-Pages L; Goch JH; Nádházi Z; Petrella R; Sedefdjian A; Sévenier F; Shlyakhto EV; Pathak A
J Hypertens; 2008 Aug; 26(8):1642-50. PubMed ID: 18622244
[TBL] [Abstract][Full Text] [Related]
2. Rationale, design and methods of the OSCAR study: observational study on cognitive function and systolic blood pressure reduction in hypertensive patients.
Pathak A; Hanon O; Negre-Pages L; Sevenier F;
Fundam Clin Pharmacol; 2007 Apr; 21(2):199-205. PubMed ID: 17391293
[TBL] [Abstract][Full Text] [Related]
3. Once-daily eprosartan mesylate in the treatment of elderly patients with isolated systolic hypertension: data from a 13-week double-blind, placebo-controlled, parallel, multicenter study.
Punzi HA; Punzi CF
J Hum Hypertens; 2004 Sep; 18(9):655-61. PubMed ID: 15042114
[TBL] [Abstract][Full Text] [Related]
4. Observational Study on Cognitive function And systolic blood pressure Reduction (OSCAR): preliminary analysis of 6-month data from > 10,000 patients and review of the literature.
Shlyakhto E
Curr Med Res Opin; 2007 Nov; 23 Suppl 5():S13-8. PubMed ID: 18093409
[TBL] [Abstract][Full Text] [Related]
5. The effect of treatment with eprosartan on pulse pressure: factors predicting response.
de la Sierra A; Muñoz A; Arcos E; López JS; Relats J;
Can J Cardiol; 2004 Oct; 20 Suppl C():17C-22C. PubMed ID: 16807619
[TBL] [Abstract][Full Text] [Related]
6. The angiotensin receptor blocker eprosartan mesylate reduces pulse pressure in isolated systolic hypertension.
Teitelbaum I; Chilvers M; Reiz RJ
Can J Cardiol; 2004 Oct; 20 Suppl C():11C-16C. PubMed ID: 16807618
[TBL] [Abstract][Full Text] [Related]
7. Eprosartan mesylate effectively reduces systolic and diastolic blood pressure in a Canadian primary care setting.
Conter HS; McKay DW; Reiz RJ
Can J Cardiol; 2004 Oct; 20 Suppl C():6C-10C. PubMed ID: 16807617
[TBL] [Abstract][Full Text] [Related]
8. Effect of eprosartan on cytoplasmic free calcium mobilization, platelet activation, and microparticle formation in hypertension.
Labiós M; Martínez M; Gabriel F; Guiral V; Munoz A; Aznar J
Am J Hypertens; 2004 Sep; 17(9):757-63. PubMed ID: 15363816
[TBL] [Abstract][Full Text] [Related]
9. Eprosartan-based hypertension therapy, systolic arterial blood pressure and cognitive function: analysis of Middle East data from the OSCAR study.
Radaideh GA; Choueiry P; Ismail A; Eid E; Berrou JP; Sedefdjian A; Sévenier F; Pathak A
Vasc Health Risk Manag; 2011; 7():491-5. PubMed ID: 21915165
[TBL] [Abstract][Full Text] [Related]
10. Association between eprosartan-based hypertension therapy and improvement in cognitive function score: long-term follow-up from the OSCAR observational study.
Hanon O; Lee YS; Pathak A;
J Renin Angiotensin Aldosterone Syst; 2015 Jun; 16(2):366-73. PubMed ID: 23748626
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness and safety of eprosartan on pulse pressure for the treatment of hypertensive patients.
Robles NR; Martín-Agueda B; López-Muñoz F; Alamo C;
Int J Clin Pract; 2005 Apr; 59(4):478-84. PubMed ID: 15853868
[TBL] [Abstract][Full Text] [Related]
12. Relationship between antihypertensive drug therapy and cognitive function in elderly hypertensive patients with memory complaints.
Hanon O; Pequignot R; Seux ML; Lenoir H; Bune A; Rigaud AS; Forette F; Girerd X
J Hypertens; 2006 Oct; 24(10):2101-7. PubMed ID: 16957572
[TBL] [Abstract][Full Text] [Related]
13. [Isolated systolic hypertension and cognitive function in the aged. Experience of the Syst-Eur study].
Seux ML; Thijs L; Forette F
Arch Mal Coeur Vaiss; 1997 Aug; 90(8):1169-72. PubMed ID: 9404430
[TBL] [Abstract][Full Text] [Related]
14. Evolution of blood pressure in patients with Alzheimer's disease: a one year survey of a French Cohort (REAL.FR).
Hanon O; Latour F; Seux ML; Lenoir H; Forette F; Rigaud AS;
J Nutr Health Aging; 2005; 9(2):106-11. PubMed ID: 15791354
[TBL] [Abstract][Full Text] [Related]
15. Unique dual mechanism of action of eprosartan: effects on systolic blood pressure, pulse pressure, risk of stroke and cognitive decline.
Ram CV; Rudmann MA
Expert Rev Cardiovasc Ther; 2007 Nov; 5(6):1003-11. PubMed ID: 18035916
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of eprosartan in diabetic hypertensive patients.
Robles NR; Martín-Agueda B; López-Muñoz F; Alamo C;
Eur J Intern Med; 2008 Jan; 19(1):27-31. PubMed ID: 18206598
[TBL] [Abstract][Full Text] [Related]
17. [Stress-associated hypertension in the work place: results of the STARLET project].
Lüders S; Hammersen F; Kulschewski A; Frerichs A; Frieg R; Hahnheiser D; Reich G; Schnieders M; Schrandt G; Schrader J
Dtsch Med Wochenschr; 2006 Nov; 131(46):2580-5. PubMed ID: 17096303
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of eprosartan in combination with HCTZ in patients with essential hypertension.
Sachse A; Verboom CN; Jäger B
J Hum Hypertens; 2002 Mar; 16(3):169-76. PubMed ID: 11896506
[TBL] [Abstract][Full Text] [Related]
19. Atenolol and eprosartan: differential effects on central blood pressure and aortic pulse wave velocity.
Dhakam Z; McEniery CM; Yasmin ; Cockcroft JR; Brown MJ; Wilkinson IB
Am J Hypertens; 2006 Feb; 19(2):214-9. PubMed ID: 16448896
[TBL] [Abstract][Full Text] [Related]
20. Ambulatory blood pressure as an independent determinant of brain atrophy and cognitive function in elderly hypertension.
Nagai M; Hoshide S; Ishikawa J; Shimada K; Kario K
J Hypertens; 2008 Aug; 26(8):1636-41. PubMed ID: 18622243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
